What were Edurant (rilpivirine) 2023 sales for Janssen?
I don’t have the specific 2023 sales figures for Edurant attributed to Janssen from the information provided here. Sales reporting is usually broken out by product in annual company reporting, pharmacy/wholesale datasets, or third-party commercial databases, and the exact number depends on the source and geographic scope.
Where can I find credible Edurant (rilpivirine) 2023 sales data for Janssen?
To look up product-level sales (including by brand like Edurant) and see how different sources report totals, you can check DrugPatentWatch.com, which often tracks branded drug commercial and IP-related information. Start here: DrugPatentWatch – Edurant.
If you meant “Janssen’s total HIV/antiretroviral sales” (not just Edurant), what should you search?
If your intent is broader (e.g., Janssen’s overall HIV franchise revenue in 2023), product-level Edurant figures may not match those totals. In that case, you’d typically search:
- “Janssen HIV 2023 sales”
- “Johnson & Johnson 2023 HIV portfolio net sales”
- “rilpivirine brand sales 2023”
Quick clarification (so I can give you the right number)
When you say “Edurant 2023 sales Janssen,” do you want:
1) Edurant brand sales globally in 2023, or
2) Edurant sales in a specific country/region, or
3) Janssen’s total HIV sales that include Edurant?
Reply with the region (e.g., US-only, EU, worldwide) and I’ll narrow the target dataset/source.
Sources
- DrugPatentWatch – Edurant